CAS 577778-58-6
:Topiroxostat
Description:
Topiroxostat is a novel pharmaceutical compound primarily used as a xanthine oxidase inhibitor, which plays a crucial role in the management of hyperuricemia and gout. It functions by reducing uric acid production in the body, thereby helping to lower serum uric acid levels. Topiroxostat is characterized by its selective inhibition of xanthine oxidase, which distinguishes it from other treatments in this category. The compound is typically administered orally and has been studied for its efficacy and safety profile in clinical settings. In terms of its chemical structure, Topiroxostat features a unique arrangement of functional groups that contribute to its biological activity. Its pharmacokinetic properties include absorption, distribution, metabolism, and excretion characteristics that are essential for determining dosing regimens. Overall, Topiroxostat represents a significant advancement in the treatment of conditions associated with elevated uric acid levels, offering an alternative to traditional therapies.
Formula:C13H8N6
InChI:InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)
InChI key:InChIKey=UBVZQGOVTLIHLH-UHFFFAOYSA-N
SMILES:C(#N)C1=CC(C=2NC(=NN2)C=3C=CN=CC3)=CC=N1
Synonyms:- 2-Pyridinecarbonitrile, 4-[3-(4-pyridinyl)-1H-1,2,4-triazol-5-yl]-
- 2-Pyridinecarbonitrile, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-
- 4-[3-(4-Pyridinyl)-1H-1,2,4-triazol-5-yl]-2-pyridinecarbonitrile
- 5-(2-Cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole
- Fyx 051
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Topiroxostat
CAS:<p>Topiroxostat (FYX-051) is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout.</p>Formula:C13H8N6Purity:99.28%Color and Shape:SolidMolecular weight:248.244-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile
CAS:Formula:C13H8N6Purity:98%Color and Shape:Liquid, No data available.Molecular weight:248.249
